5-151253301-A-G
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 2P and 3B. PM2BP4_ModerateBS1_Supporting
The ENST00000357164.4(GM2A):c.81+4A>G variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000535 in 1,606,134 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000357164.4 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GM2A | NM_000405.5 | c.81+4A>G | splice_region_variant, intron_variant | ENST00000357164.4 | NP_000396.2 | |||
GM2A | NM_001167607.3 | c.81+4A>G | splice_region_variant, intron_variant | NP_001161079.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GM2A | ENST00000357164.4 | c.81+4A>G | splice_region_variant, intron_variant | 1 | NM_000405.5 | ENSP00000349687.3 | ||||
GM2A | ENST00000523466.5 | c.127-6454A>G | intron_variant | 3 | ENSP00000429100.1 |
Frequencies
GnomAD3 genomes AF: 0.000276 AC: 42AN: 152108Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000518 AC: 13AN: 250828Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135654
GnomAD4 exome AF: 0.0000296 AC: 43AN: 1453908Hom.: 0 Cov.: 29 AF XY: 0.0000193 AC XY: 14AN XY: 723834
GnomAD4 genome AF: 0.000282 AC: 43AN: 152226Hom.: 0 Cov.: 32 AF XY: 0.000296 AC XY: 22AN XY: 74432
ClinVar
Submissions by phenotype
Tay-Sachs disease, variant AB Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 26, 2022 | This sequence change falls in intron 1 of the GM2A gene. It does not directly change the encoded amino acid sequence of the GM2A protein. It affects a nucleotide within the consensus splice site. This variant is present in population databases (rs368443364, gnomAD 0.08%). This variant has not been reported in the literature in individuals affected with GM2A-related conditions. Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant is not likely to affect RNA splicing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at